Premium
Real‐Time In Vivo Quantitative Monitoring of Drug Release by Dual‐Mode Magnetic Resonance and Upconverted Luminescence Imaging
Author(s) -
Liu Jianan,
Bu Jiwen,
Bu Wenbo,
Zhang Shengjian,
Pan Limin,
Fan Wenpei,
Chen Feng,
Zhou Liangpin,
Peng Weijun,
Zhao Kuaile,
Du Jiulin,
Shi Jianlin
Publication year - 2014
Publication title -
angewandte chemie international edition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.831
H-Index - 550
eISSN - 1521-3773
pISSN - 1433-7851
DOI - 10.1002/anie.201400900
Subject(s) - in vivo , dual mode , magnetic resonance imaging , drug delivery , drug , luminescence , biomedical engineering , materials science , nanotechnology , chemistry , pharmacology , medicine , radiology , optoelectronics , biology , microbiology and biotechnology , engineering , aerospace engineering
Insufficient or excess drug doses, due to unknown actual drug concentrations at the focus, are one of the main causes of chemotherapy failure for cancers. In this regard, the real‐time monitoring of the release of anticancer drugs from nanoparticle drug delivery systems is of crucial importance, but it remains a critical and unsolved challenge. Herein, we report the proposal and development of a novel concept of real‐time monitoring of NIR‐triggered drug release in vitro and in vivo by using simultaneous upconverted luminescence (UCL) and magnetic resonance (MR) imaging. Such a monitoring strategy features the high sensitivity of UCL and the high‐resolution, noninvasiveness, and tissue‐depth‐independence of MR imaging. The dual‐mode real‐time and quantitative monitoring of drug release can be applied to determine online the drug concentrations in vivo in the tissue regions of interest and, therefore, to avoid insufficient or excess drug dosings.